Skip to content
Search

Latest Stories

Top manufacturer warns 'massive shortage' of ventilators in UK

Britain faces a "massive shortage" of ventilators that will be needed to treat critically ill patients suffering from coronavirus, after it failed to invest enough in intensive care equipment, a leading ventilator manufacturer said on Wednesday.

"England is very poorly equipped," said Andreas Wieland, chief executive of Hamilton Medical in Switzerland, which says it is the world's largest ventilator maker.


"They're going to have a massive shortage, once the virus really arrives there," he told Reuters in an interview.

Ventilators, running in the thousands of dollars per unit, are used to help people with respiratory difficulties to breathe. Worldwide, the devices have become shorthand for the rapid advance of the disease.

Germany's Draegerwerk last week got a government order for 10,000, equal to a typical year's production.

Wieland's company in the Swiss Alps has boosted normal production of some 15,000 ventilators annually by 30-40% and now can produce about 80 ventilators daily.

Last week, the company shipped 400 ventilators to Italy, whose intensive care units have been overwhelmed by more than 35,000 cases of the rapidly spreading virus and almost 3,000 deaths.

About 50% of those with coronavirus in Italy accepted into intensive care units are dying, compared with typical mortality rates of 12% to 16% in such units.

Wieland said a similar outbreak in Britain, now with more than 2,600 cases and over 110 deaths, would swamp the system there, too.

"They are not well equipped with ventilators and intensive care stations," he said. "They invested very little, and I think now they will pay the price."

Health Secretary Matt Hancock has acknowledged the existing stock of 5,000 ventilators is inadequate.

"We think we need many times more than that and we are saying if you produce a ventilator then we will buy it," he said earlier this week. "No number is too high."

Wieland said he was in "close contact" with UK medical leaders and aimed to prioritise shipments there soon, though for now Italy was taking precedence. He also has orders from the United States, Turkey, France and China.

Wieland is skeptical, however, of the British government's recent call for manufacturers from other industries including Ford, Honda and Rolls Royce to help make equipment including ventilators.

"I wish them the best of luck," Wieland said. "I do not believe anything will come of it. These devices are very complex. It takes us four to five years" to develop a new product.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less